Antihyperuricemic and diuretic effects of procyanidins extracted from Crataegus monogyna

Kawa Dizaye

doi:10.15218/zjms.2011.0009

Authors

Kawa Dizaye Department of Pharmacology, College of Medicine, HMU, Erbil, Iraq

DOI:

https://doi.org/10.15218/zjms.2011.0009

Keywords:

Procyanidins, Hypouricemic effect, Uric acid adenosine deaminase, 5-nucleo tidase

Abstract

Background and objectives: Data indicated that procyanidins extracted from grape seeds has uric acid-lowering effects in mice, however the hypouricaemic effect of procyanidins was accompanied with changes in enzymatic activities of xanthine dehydrogenase and xanthine oxidase. This study was designed to investigate the effect of procyanidins extracted from Crataegus monogyna on serum uric acid, adenosine deaminase (ADA), 5-nucleotidase, xanthine oxidase, and renal function on normal and potassium oxonate induced hyperuricemic rats.

Methods: Thirty female albino rats were divided into three groups. The first group included 18 rats pretreated with the uricase inhibitor potassium oxonate (250 mg/kg, i.p.), served as an animal model for hyperuricemia. The rat models were divided into three subgroups, each subgroup having six rats. The first subgroup served as a normal control. Subgroup 2 received a single daily dose (100 mg/kg p.o) of procyanidins for 7 days. The third subgroup received daily dose (50 mg/kg p.o) of allopurinol for 7 days as positive control. The second group included six rats received only water as a vehicle. The serum uric acid, xanthine oxidase, adenosine deaminase (ADA) and 5-nucleotidase levels were measured and compared to those in normal untreated control group. The Third group included six normal rats received a single dose of Procyanidins (50 mg/kg body weight; i.v.) to study the renal effects of procyanidins..

Results: A single daily dose (100 mg/kg PO) of procyanidins for 7 days significantly reduced serum levels of uric acid, ADA and 5’-nucleotidase, without detectable effects on the level of xanthine oxidase in hyperuricemic rats. Intravenous infusion of a single dose of procyanidins (50 mg/kg i.v) produced marked increases in urinary Na⁺ excretion (4.8 folds) and urine flow (2.6 folds) accompanied by insignificant change of potassium excretion in the rats.

Conclusion: The reduction in serum uric acid most probably is due to inhibiting enzymes, ADA and 5-nucleotidase. The antihyperuricemic and diuretic effects of procyanidins recommended it as a good drug for the treatment of gout and renal uric acid calculi.

Metrics

Metrics Loading ...

References

- Chen LX, Schumacher HR. "Gout: an evidence-based review". J Clin Rheumatol 2008,14 (5 Suppl): S55–62

- Tausche AK, Jansen TL, Schröder HE, Bornstein SR, Aringer M, Müller-Ladner U. "Gout--current diagnosis and treatment". Dtsch Arztebl Int 106 (34-35): 549–55. doi:10.3238/arztebl, 2009. 0549. PMID 19795010.

- Kramer HM, Curhan G. "The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III", 1988-1994. Am J Kidney Dis 2002; 40:37-42.

- Sturrock R . "Gout. Easy to misdiagnose". BMJ 320 (7228): 132–3. doi: 2000, 10.1136 / bmj.320.7228.132. PMID 10634714.

- Robert K. Murray, Daryl K. Granner, Daryl K. Granner "Harper’s Illustrated Biochemistry". 27th edition. chapter 34. 2003: p 299

- Yu TF, Gutman AS. "Uric acid nephrolithiasis in gout". Annals Intern Med 1967; 67:113348.

- Borges F. Fernandes E. and Roliera, F "Progresses towards the discovery of xanthine oxidase inhibitors" 2002 Curr Med. Chem 9, 195-217

- Chou CT and Kuo SC. "The anti-inflammatory and anti-hyperuricemic effects of Chinese herbal formula danggui-nian-tong-tang on acute gouty arthritis: a comparative study with indomethacin and allopurinol". Am J Chin Med 1995, 23:261–271

- Wang Ying; Zhu Ji Xiao; Kong Ling Dong; Yang Cheng; Cheng Christopher Hon Ki; Zhang Xin. "Administration of Procyanidins from Grape Seeds Reduces Serum Uric Acid Levels and Decreases Hepatic Xanthine Dehydrogenase/Oxidase Activities in Oxonate-Treated Mice". Basic & Clinical Pharmacology &Toxicology, Volume 94, 5, 2004, pp. 232-237(6)

- Dizaye K. AL-Jeboory A. Al-Jaff H. "The pharmacological studies of procyanidine (A new drug for the treatment of heart failure". PJP. 22, No.1, 2005; 22:57-79.

- British Herbal Pharmacopeia (1996). "Published by the British Herbal Medicine Association".

- Svedstrom U., Vuorela H. and Kostiainen R. "Isolation and identification of oligomeric procyanidins from Crataegus leaves and flowers". Phytochemistr. 2002, 60 (8): 821-825.

- Laber K., Swindle M. and Fleckneell P "Rodent and Rabbit medicine" BPC Wheatons Ltd., 1996 Exeter U.K. First Edition

- Harold Varley. "Practical Clinical Biochemistry". 4th edit. CBS publishers and distributors, Delhi, India. 1988, 446-447.

- Carroll J.J, Roberta Douglass, Babson A.L. "A simplified alkaline phosphotangstate assay for uric acid in serum". Clinic Chem.2005, 17: 158-160.

- Schlesinger N. "Management of acute and chronic gouty arthritis" Present state-of-the-art. Drugs 2004, 64:2399–2416.

- Yale SH, Yale ES, and Mann DS. "Fever, rash and angioedema after a course of allopurinol". Hosp Pract 1996, 31:92–94.

- Bomalaski JS and Clark MA. "Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase". Curr Rheumatol Rep 2004, 6:240–247.

- Underwood M. "Diagnosis and management of gout". BMJ 2006, 332 (7553): 1315–9.

-Osada Y, Tsuchimoto M, Fukushima H, Takahashi K, Kondo S, Hasegawa M, and Komoriya K. "Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents". Eur J Pharmacol 1993, 241:183–188.

- Sachs L, Batra KL Zimmermann B."Medical implications of hyperuricemia". Med Health R I 2009, 92 (11): 353–55.

- Franse, L.V., Pahor, M., Di Bari, M. "Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension", 2000, 35:1025-1030